SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1.76 |
| Enterprise Value ($M) | 63.27 |
| Book Value ($M) | 57.80 |
| Book Value / Share | 12.13 |
| Price / Book | 0.03 |
| NCAV ($M) | 55.87 |
| NCAV / Share | 11.72 |
| Price / NCAV | 0.03 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.31 |
| Return on Assets (ROA) | -0.20 |
| Return on Equity (ROE) | -0.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.03 |
| Current Ratio | 3.03 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 83.48 |
| Assets | 85.41 |
| Liabilities | 27.61 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -15.62 |
| Net Income | -18.06 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -9.22 |
| Cash from Investing | 0.09 |
| Cash from Financing | 5.58 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,152 | 18,146 | 17.37 | |
| 125 | 17,622 | 0.71 | |
| 22,807 | 129,591 | 17.60 | |
| 59,275 | 133,853 | 44.28 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ELUT – Elutia Inc. | ENLV – Enlivex Therapeutics Ltd. |
| ENSC – Ensysce Biosciences, Inc. | ENTX – Entera Bio Ltd. |
| ENVB – Enveric Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io